We are live on ! Find out more
BGMS

Bio Green Med Solution Inc

3 hedge funds and large institutions have $948K invested in Bio Green Med Solution Inc in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

1% less capital invested

Capital invested by funds: $960K → $948K (-$12.3K)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$108K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$36K
2
Citadel Advisors
Citadel Advisors
Florida
-$19K

BGMS Hedge Fund Activity: Q3 2018 in Review

3 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q3 2018, worth a combined $948K — down 1.3% from $960K a quarter earlier.

Fund positioning in BGMS was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $108K. The largest seller was Sabby Management, cutting an estimated $36K.

  • 3 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $948K of Bio Green Med Solution Inc stock for Q3 2018, down 1.3% quarter-over-quarter.
  • 0 funds opened new Bio Green Med Solution Inc positions in Q3 2018 and 0 closed out.
  • The largest Bio Green Med Solution Inc buyer in Q3 2018 was Renaissance Technologies, an estimated $108K added.
  • The largest Bio Green Med Solution Inc seller in Q3 2018 was Sabby Management, an estimated $36K sold.

Based on aggregated 13F filings for Q3 2018.